Merck Sharp & Dohme Research Labs
Executive Summary
Charles Leighton, MD, senior VP-worldwide regulatory affairs, promoted to senior VP-worldwide medical and regulatory affairs; W. John Powell, MD, director-clinical research to VP-clinical research; Eve Slater, MD, executive director-biochemistry and molecular biology to executive director-clinical and regulatory development.